Hema Now
In this episode of Hema Now, we sit down with Toby Eyre, Consultant Haematologist at Oxford University Hospitals, to explore the latest advances in lymphoma and CLL, discuss unanswered questions in mantle cell lymphoma, and consider how emerging research is shaping the future of lymphoma care.
Spotify | Apple | Amazon Music | YouTube | Download MP3
Toby Eyre is a Consultant Haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies, including lymphoma and chronic lymphocytic leukaemia. His research interests include clinical trials, novel targeted therapies, biomarkers and the management of complex lymphoid malignancies.
Timestamps:
00:00 – Introduction
01:04 – Journey into haematology and lymphoma
04:34 – Working at Oxford University Hospitals
06:55 – Advances in lymphoma and CLL
11:00 – Unanswered questions in mantle cell lymphoma
16:22 – Impact of major haematology conferences
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
